Skip to content

Clinical study on the effect of acupuncture on pregnancy outcome of frozen embryo transplantation in infertile patients (non-POR)

Clinical study on the effect of acupuncture on pregnancy outcome of frozen embryo transplantation in infertile patients (non-POR)

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000041237
Enrollment
Unknown
Registered
2020-12-22
Start date
2021-03-16
Completion date
Unknown
Last updated
2021-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Interventions

treatment group:acupuncture

Sponsors

Beijing Chaoyang Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 38 Years

Inclusion criteria

Inclusion criteria: 1. Subjects who met the diagnostic criteria of infertility and could exclude low ovarian response; 2. Women aged between 20 and 38; 3. Subjects undergoing IVF / ICSI / PGD assisted pregnancy and those planning embryo transfer; 4. IVF / ICSI transferred 1-2 D3 cleavage embryos or blastocysts with good quality, while PGD blastocysts only transferred 1; 5. Those subjects who have informed consent and are willing to accept clinical trial observers.

Exclusion criteria

Exclusion criteria: 1. Patients with por diagnosis; 2. Patients with endometrial lesions (including endometritis, endometrial polyps and intrauterine adhesions); 3. Patients with uterine malformation (single horn uterus, double horn uterus, double uterus, mediastinal uterus); 4. Patients with organic lesions of reproductive organs, such as adenomyosis, hysteromyoma and ovarian cyst; 5. Patients with submucous myoma and intramural myoma that oppresses uterine cavity line; 6. Abnormal karyotype of the patient or her husband; 7. Patients with contraindications of assisted reproductive technology or pregnancy; 8. Patients with serious primary diseases and mental diseases such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic system; 9. Patients who have received treatment (such as acupuncture and traditional Chinese Medicine) related to regulating menstruation and helping pregnancy in recent 3 months; 10. Patients who are participating in other clinical drug trials.

Design outcomes

Primary

MeasureTime frame
clinical pregnancy rate;

Secondary

MeasureTime frame
persistent pregnancy rate;endometrial receptivity;

Countries

China

Contacts

Public ContactYuan Li

Beijing Chaoyang Hospital Affiliated to Capital Medical University

904605734@qq.com+86 18611676757

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026